Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/5397| Title: | Olaparib and bevacizumab in frontline maintenance of ovarian cancer: An over reliance in unpowered subgroup analysis of the PAOLA-1 trial? |
| Authors: | Paulino, Eduardo Melo, Andreia Cristina de |
| Keywords: | Neoplasias Ovarianas Ovarian Neoplasms Bevacizumab |
| Issue Date: | 2020 |
| Publisher: | J Gynecol Oncol. |
| Citation: | PAULINO, Eduardo; MELO, Andreia Cristina de. Olaparib and bevacizumab in frontline maintenance of ovarian cancer: An over reliance in unpowered subgroup analysis of the PAOLA-1 trial? J Gynecol Oncol., v. 31, v. 06, p. 1-5, nov. 2020. |
| Description: | p. 1-5.: tab. p&b. |
| URI: | http://sr-vmlxaph03:8080/jspui/handle/123456789/5397 |
| ISSN: | 2005-0399 |
| Appears in Collections: | Artigos de Periódicos da área de Oncologia Clínica |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Olaparib and bevacizumab in frontline maintenance of ovarian cancer An over reliance in unpowered subgroup.pdf | 334.98 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.